Activated CXCL2-CXCR2 signaling recruits and activates BRM/macrophages through the activation of extracellular signal−regulated protein kinase 1 and 2 (ERK1/2) and AKT signaling pathways, thereby promoting the GBM progression (63). The gene discussed is MAPK3; the disease is glioblastoma.